Trial Information
Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors
Inclusion Criteria:
- Patient aged over 18 years
- Ovarian cancer patients with at least five tumor samples does not affect the
diagnosis, based on other tumor masses
- Surgery of any initial chemotherapy naive
- Patient information and signed informed consent
Exclusion Criteria:
- A person deprived of liberty or under guardianship
- Insufficient tumor samples of ovarian cancer.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
rate of apoptotic cells
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
JOLY Florence, Pr
Investigator Role:
Principal Investigator
Investigator Affiliation:
Centre françois Baclesse
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
ABT-737 ex vivo
NCT ID:
NCT01440504
Start Date:
April 2010
Completion Date:
January 2013
Related Keywords:
- Ovarian Cancer
- Cancer
- Ovarian
- chemotherapy
- BH3-mimetic
- platin
- ex-vivo
- Ovarian Neoplasms